ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NGNE Neurogene Inc

16.70
-0.10 (-0.60%)
15 Mar 2025 - Closed
Delayed by 15 minutes

Neurogene Financial Summary

The current NGNE market cap is 248.07M. The company's latest EPS is USD -2.4448 and P/E is -6.81.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000925k0
Operating Income -5.57M-31.82M-18.78M-20.13M-22.18M
Net Income -4.53M-15.5M-16.92M-18.49M-20.22M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 07.83M000
Operating Income -70.96M-33.73M-60.7M-59.1M-55.58M
Net Income -69.44M-33.28M-60.69M-57.56M-36.32M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 89.59M222.57M195.35M179.82M164.12M
Total Liabilities 14.35M36.55M24.57M24.81M26.71M
Total Equity 75.24M186.02M170.78M155.01M137.41M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 147.02M210.52M163.26M115.95M222.57M
Total Liabilities 5.34M19.3M20.4M21.62M36.55M
Total Equity 141.69M191.22M142.86M94.33M186.02M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -21.35M-51.42M-21.65M-37.54M-53.11M
Investing 8.68M25.64M29.94M6.32M-22.65M
Financing -361k92.48M-6.52M-6.13M-5.99M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -15.39M-24.58M-47.56M-45.61M-51.42M
Investing -688k-2.22M-3.26M-59.13M25.64M
Financing 82.24M77.14M732k161k92.48M
Market Cap 248.07M
Price to Earnings Ratio -6.81
Price to Sales Ratio 0
Price to Cash Ratio 1.67
Price to Book Ratio 1.33
Dividend Yield -

Share Statistics

Shares Outstanding 14.85M
Average Volume (1 week) 136.2k
Average Volume (1 Month) 170.58k
52 Week Change -53.04%
52 Week High 74.49
52 Week Low 14.42
Spread (Intraday) 75.09 (82.7%)

Company Info

Company Name Neurogene Inc
Address corporation trust center 1209 orange st
wilmington, delaware 19802
Website https://www.neoleukin.com
Industry pharmaceutical preparations (2834)